D-Index & Metrics Best Publications
Medicine
Netherlands
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 116 Citations 77,562 605 World Ranking 2438 National Ranking 82

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Netherlands Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Endocrinology

His primary areas of study are Internal medicine, Endocrinology, Renal function, Kidney disease and Albuminuria. His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus, Nephropathy and Type 2 diabetes. His biological study spans a wide range of topics, including Risk factor and Urology.

His Renal function study integrates concerns from other disciplines, such as Nephrology, Heart failure, Cardiology, Kidney and Enalapril. His Kidney disease research includes themes of Gastroenterology, Dialysis, End stage renal disease and Intensive care medicine. His Albuminuria study also includes fields such as

  • Diabetic nephropathy that intertwine with fields like Ramipril,
  • Surgery that intertwine with fields like Placebo-controlled study.

His most cited work include:

  • EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY (5734 citations)
  • Canagliflozin and cardiovascular and renal events in type 2 diabetes (2888 citations)
  • Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) (2383 citations)

What are the main themes of his work throughout his whole career to date?

Dick de Zeeuw mainly investigates Internal medicine, Endocrinology, Renal function, Albuminuria and Kidney disease. His research integrates issues of Cardiology, Diabetes mellitus, Nephropathy, Type 2 diabetes and Urology in his study of Internal medicine. His Diabetes mellitus research focuses on Intensive care medicine and how it relates to Clinical trial.

His research in Urology focuses on subjects like Losartan, which are connected to Pharmacology. Dick de Zeeuw has included themes like Nephrology, Urinary system, Creatinine, Prospective cohort study and End stage renal disease in his Renal function study. His Albuminuria research integrates issues from Surgery, Urine, Microalbuminuria and Risk factor.

He most often published in these fields:

  • Internal medicine (71.45%)
  • Endocrinology (40.20%)
  • Renal function (31.42%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (71.45%)
  • Type 2 diabetes (24.49%)
  • Kidney disease (26.52%)

In recent papers he was focusing on the following fields of study:

Dick de Zeeuw focuses on Internal medicine, Type 2 diabetes, Kidney disease, Canagliflozin and Albuminuria. The study incorporates disciplines such as Diabetes mellitus, Endocrinology, Placebo and Cardiology in addition to Internal medicine. His Type 2 diabetes research incorporates elements of Metformin, Oncology, Blood pressure, Post-hoc analysis and Hazard ratio.

His research investigates the link between Canagliflozin and topics such as Heart failure that cross with problems in Myocardial infarction. His Albuminuria research is multidisciplinary, relying on both Surgery, Cohort study, Microalbuminuria, Excretion and Surrogate endpoint. His research in Renal function intersects with topics in Biomarker, Urology, Disease, Creatinine and Prospective cohort study.

Between 2015 and 2021, his most popular works were:

  • Canagliflozin and cardiovascular and renal events in type 2 diabetes (2888 citations)
  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (1296 citations)
  • Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study) (228 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Kidney

The scientist’s investigation covers issues in Internal medicine, Kidney disease, Diabetes mellitus, Type 2 diabetes and Canagliflozin. His Internal medicine research is multidisciplinary, incorporating perspectives in Empagliflozin, Placebo, Endocrinology and Cardiology. Dick de Zeeuw focuses mostly in the field of Kidney disease, narrowing it down to topics relating to Renal function and, in certain cases, Urology, Clinical trial and Randomized controlled trial.

Dick de Zeeuw combines subjects such as Cohort and MEDLINE with his study of Diabetes mellitus. His Type 2 diabetes research is multidisciplinary, incorporating elements of Creatinine, Gastroenterology and Blood pressure. His work carried out in the field of Albuminuria brings together such families of science as Surgery, Microalbuminuria and Surrogate endpoint.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY

Barry M. Brenner;Mark E. Cooper;Dick De Zeeuw;William F. Keane.
The New England Journal of Medicine (2001)

8761 Citations

Canagliflozin and cardiovascular and renal events in type 2 diabetes

Bruce Neal;Vlado Perkovic;Vlado Perkovic;Kenneth W. Mahaffey;Dick de Zeeuw.
The New England Journal of Medicine (2017)

5609 Citations

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Andrew S. Levey;Kai-Uwe Eckardt;Yusuke Tsukamoto;Adeera Levin.
Kidney International (2005)

4230 Citations

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint.
The New England Journal of Medicine (2019)

3075 Citations

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson.
The Lancet (2011)

2913 Citations

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper.
The New England Journal of Medicine (2009)

2176 Citations

Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population

Hans L. Hillege;Vaclav Fidler;Gilles F.H. Diercks;Wiek H. van Gilst.
Circulation (2002)

1681 Citations

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

Hans-Henrik Parving;Hans-Henrik Parving;Barry M. Brenner;John J.V. McMurray;Dick de Zeeuw.
The New England Journal of Medicine (2012)

1401 Citations

Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition - A patient-level meta-analysis

Tazeen H. Jafar;Paul C. Stark;Christopher H. Schmid;Marcia Landa.
Annals of Internal Medicine (2003)

1392 Citations

Renal function, neurohormonal activation, and survival in patients with chronic heart failure

Hans L. Hillege;Armand R. J. Girbes;Pieter J. de Kam;Frans Boomsma.
Circulation (2000)

1342 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Dick de Zeeuw

Ron T. Gansevoort

Ron T. Gansevoort

University Medical Center Groningen

Publications: 261

Peter Rossing

Peter Rossing

University of Copenhagen

Publications: 257

Stephan J. L. Bakker

Stephan J. L. Bakker

University Medical Center Groningen

Publications: 233

Gerjan Navis

Gerjan Navis

University Medical Center Groningen

Publications: 221

Giuseppe Remuzzi

Giuseppe Remuzzi

Mario Negri Institute for Pharmacological Research

Publications: 197

George L. Bakris

George L. Bakris

University of Chicago

Publications: 195

Hiddo J.L. Heerspink

Hiddo J.L. Heerspink

University of Groningen

Publications: 190

Luis M. Ruilope

Luis M. Ruilope

European University of Madrid

Publications: 174

Andrew S. Levey

Andrew S. Levey

Tufts Medical Center

Publications: 166

Josef Coresh

Josef Coresh

Johns Hopkins University

Publications: 162

Michael G. Shlipak

Michael G. Shlipak

University of California, San Francisco

Publications: 156

Matthew R. Weir

Matthew R. Weir

University of Maryland, Baltimore

Publications: 150

Csaba P. Kovesdy

Csaba P. Kovesdy

University of Tennessee Health Science Center

Publications: 148

Vlado Perkovic

Vlado Perkovic

George Institute for Global Health (Australia)

Publications: 130

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 129

Christoph Wanner

Christoph Wanner

University of Würzburg

Publications: 129

Trending Scientists

Karen Willcox

Karen Willcox

The University of Texas at Austin

Miklas Scholz

Miklas Scholz

University of Salford

Jorunn Sletten

Jorunn Sletten

University of Bergen

Tetsuo Soga

Tetsuo Soga

Nagoya Institute of Technology

David J. Kemp

David J. Kemp

Walter and Eliza Hall Institute of Medical Research

Mahmood S. Shivji

Mahmood S. Shivji

Nova Southeastern University

David H. Secor

David H. Secor

University of Maryland Center For Environmental Sciences

Joaquín Jordán

Joaquín Jordán

University of Castilla-La Mancha

Serge Heussner

Serge Heussner

Centre national de la recherche scientifique, CNRS

Guibing Zhu

Guibing Zhu

Chinese Academy of Sciences

Vadim Y. Bolshakov

Vadim Y. Bolshakov

Harvard University

Piotr Kuna

Piotr Kuna

Medical University of Lodz

Robbert Sanderman

Robbert Sanderman

University Medical Center Groningen

Elizabeth J. Marsh

Elizabeth J. Marsh

Duke University

Angelo A. Izzo

Angelo A. Izzo

University of Naples Federico II

Geert R. D'Haens

Geert R. D'Haens

University of Amsterdam

Something went wrong. Please try again later.